New Oral Agent Shows Clinical Activity in Rare C3 Glomerulopathy New Oral Agent Shows Clinical Activity in Rare C3 Glomerulopathy

A new oral complement inhibitor showed clinically meaningful activity, compared with placebo, in a rare kidney disease.Medscape Medical News
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news